Breast Lesion Localization Methods Market - 2024-2031

August 2024 | 60 pages | ID: B3C787C12BA8EN
DataM Intelligence

Abstracts

Breast Lesion Localization Methods Market reached US$ 363.87 million in 2023 and is expected to reach US$ 795.15 million by 2031, growing with a CAGR of 10.50% during the forecast period 2026-2031.

The Breast Lesion Localization Methods Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Breast Lesion Localization Methods Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Method

• Wire-Guided Localization (WGL) *
• Magnetic Tracers
• Electromagnetic Reflectors
• Radio Guided Occult-Lesion Localization (ROLL)
• Radioactive-Seed Localization (RSL)
• Others
• Breast Biopsy Marker Localization
• Others

By Devices

• Radioactive Seeds*
• Radar Reflectors
• Magnetic Seeds
• Radiofrequency Identification Tag Localizers (RFIDs)
• Wires
• Coils
• Others

Regional Analysis for Breast Lesion Localization Methods Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Breast Lesion Localization Methods Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Method
3.2. Snippet by Devices
3.3. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing incidence of breast cancer
    4.1.1.2. XX
  4.1.2. Restraints
    4.1.2.1. High cost of advanced technologies
    4.1.2.2. XX
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. BY METHOD

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  6.1.2. Market Attractiveness Index, By Method
6.2. Wire-Guided Localization (WGL) *
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Magnetic Tracers
6.4. Electromagnetic Reflectors
  6.4.1. Radio Guided Occult-Lesion Localization (ROLL)
  6.4.2. Radioactive-Seed Localization (RSL)
  6.4.3. Others
6.5. Breast Biopsy Marker Localization
6.6. Others

7. BY DEVICES

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
  7.1.2. Market Attractiveness Index, By Devices
7.2. Radioactive Seeds*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Radar Reflectors
7.4. Magnetic Seeds
7.5. Radiofrequency Identification Tag Localizers (RFIDs)
7.6. Wires
7.7. Coils
7.8. Others

8. BY REGION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  8.1.2. Market Attractiveness Index, By Region
8.2. North America
  8.2.1. Introduction
  8.2.2. Key Region-Specific Dynamics
    8.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
    8.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
  8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.2.3.1. The U.S.
    8.2.3.2. Canada
    8.2.3.3. Mexico
8.3. Europe
  8.3.1. Introduction
  8.3.2. Key Region-Specific Dynamics
    8.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
  8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.3.4.1. Germany
    8.3.4.2. UK
    8.3.4.3. France
    8.3.4.4. Italy
    8.3.4.5. Spain
    8.3.4.6. Rest of Europe
8.4. South America
  8.4.1. Introduction
  8.4.2. Key Region-Specific Dynamics
    8.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
  8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.4.4.1. Brazil
    8.4.4.2. Argentina
    8.4.4.3. Rest of South America
8.5. Asia-Pacific
  8.5.1. Introduction
  8.5.2. Key Region-Specific Dynamics
    8.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
  8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.5.4.1. China
    8.5.4.2. India
    8.5.4.3. Japan
    8.5.4.4. South Korea
    8.5.4.5. Rest of Asia-Pacific
8.6. Middle East and Africa
  8.6.1. Introduction
  8.6.2. Key Region-Specific Dynamics
    8.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices

9. COMPETITIVE LANDSCAPE

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. COMPANY PROFILES

10.1. Becton, Dickinson, and Company *
  10.1.1. Company Overview
  10.1.2. Product Portfolio and Description
  10.1.3. Financial Overview
  10.1.4. Key Developments
10.2. Sterylab S.r.l.
10.3. SOMATEX Medical Technologies GmbH
10.4. Argon Medical Devices
10.5. Hologic Inc.
10.6. Cook Medical
10.7. Mammotome
10.8. Merit Medical Systems, Inc.
10.9. Theragenics Corporation
10.10. Mermaid Medical (*LIST NOT EXHAUSTIVE)

11. APPENDIX

11.1. About Us and Services
11.2. Contact Us